Current, Emerging, and Anticipated Therapies for Sickle Cell Disease

Mayo Clinic Proceedings - Netherlands
doi 10.1016/j.mayocp.2018.10.010
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

Emerging Drugs for Sickle Cell Anemia

Expert Opinion on Emerging Drugs
Pharmacology
2014English

Superbugs: Current Trends and Emerging Therapies

2012English

Sudden Death in Sickle Cell Disease: Current Experience

British Journal of Haematology
Hematology
2019English

Review Article: Current and Emerging Therapies for Functional Dyspepsia

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2006English

Pnd92 - Access and Reimbursement for Current and Emerging Alzheimer’s Disease-Modifying Therapies in the Eu5

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Current Therapies and Emerging Targets for the Treatment of Diabetes

2012English

Rifaximin for Sickle Cell Disease

American Journal of Hematology
Hematology
2019English

Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy